Parexel International Corp. (PRXL)

Can this get back to pre market levels

Starboard Value LP has filed a new activist 13D, reporting 5.7% ownership in $PRXL - https://fintel.io/so/us/prxl

Reports that they are considering selling.
Also they are in the process of restructuring.

I've owned this stock a long time and for years it grew briskly. In recent years it's staggered but appears to be working to diversify. They have expertise in several areas and that's expanding...if Trump doesn't tromp us.
Sure hope that pays off.

Credit Suisse reiterated its buy rating on Parexel. Stock's trading @ 25% discount:

Full Analysis

Hi June:
Yup; i bought on an early Motley Fool recommendation.
They were irreverent , humble and informative then and i did quite well with PRXL and ISRG thanks to them.
Unfortunately, they've become pretty much what they used to sneer at.

I have also have owned this ticker for years and only wish I had purchased more..great issue

This board is obviously moribund; but iv'e held PRXL for a bunch of years , buying in at around $10, and it's treated me very well in the long run.
I only wish my other holdings did as well!
Don't ignore this stock!

Well on the way...

~ $PRXL ~ Earnings posted, pending or coming soon! In Charts and Links Below!

~ $PRXL ~ Earnings expected on Monday *
This Week In Earnings: Earnings are coming or are already posted! This is what the charts look like! If you play the earnings these posts can be very helpful to you!
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=PRXL&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=PRXL&p=W&b=3&g=0&id=p54550695994



~ Barchart: http://barchart.com/quotes/stocks/PRXL?
~ OTC Markets: http://www.otcmarkets.com/stock/PRXL/company-info
~ Google Finance: http://www.google.com/finance?q=PRXL
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=PRXL#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=PRXL+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=PRXL
Finviz: http://finviz.com/quote.ashx?t=PRXL
~ BusyStock: http://busystock.com/i.php?s=PRXL&v=2
~ CandlestickChart: http://www.candlestickchart.com/cgi/chart.cgi?symbol=PRXL&exchange=US
~ Investorshub Trades: http://ih.advfn.com/p.php?pid=trades&symbol=PRXL
~ Investorshub Board Search: http://investorshub.advfn.com/boards/getboards.aspx?searchstr=PRXL
~ Investorshub PostStream Search: http://investorshub.advfn.com/boards/poststream.aspx?ticker=PRXL
~ Investorshub Goodies Search: http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=18582&srchyr=2011&SearchStr=PRXL
~ Investorshub Message Search: http://investorshub.advfn.com/boards/msgsearch.aspx?SearchStr=PRXL
~ MarketWatch: http://www.marketwatch.com/investing/stock/PRXL/profile
~ E-Zone Chart: http://www.windchart.com/ezone/signals/?symbol=PRXL
~ 5-Min Wind: http://www.windchart.com/stockta/analysis?symbol=PRXL
~ 10-Min Wind: http://www.windchart.com/stockta/analysis?symbol=PRXL&size=l&frequency=10&color=g
~ 30-Min Wind: http://www.windchart.com/stockta/analysis?symbol=PRXL&size=l&frequency=30&color=g
~ 60-Min Wind: http://www.windchart.com/stockta/analysis?symbol=PRXL&size=l&frequency=60&color=g


http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.

PRXL $20 PAREXEL has been selected as one of two strategic partners by UCB (PRXL) 20.41 +0.48 : Co has been selected as one of two strategic partners by UCB to provide clinical development services worldwide. The agreement is effective for all of UCB's new clinical study programs on a global basis. Through the strategic partnership, UCB will receive the benefits of PAREXEL's proven clinical processes through all phases of development, which are supported by its market-leading eClinical technology platform. UCB will also leverage PAREXEL's consulting expertise in regulatory affairs and commercialization.

http://events.jspargo.com/asco10/public/Booth.aspx?IndexInList=1&FromPage=ExhibitorSearch.aspx&BoothID=170057

6:02AM PAREXEL announces that it has completed a large and complex pharmacogenetics-based early phase study (PRXL) 23.88 : Co announces that it has completed a large and complex pharmacogenetics-based early phase study. The study was conducted in a healthy volunteer population of poor metabolizers of Cytochrome P450 2D6, an important enzyme involved in the metabolism of drugs. The study monitored the QTc interval following administration of a neurological treatment, which has been shown to have a higher drug exposure in poor metabolizers of CYP2D6.

That was almost to the moon...very good!

To da MOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOON!!!!!!!!!!!!!!!!!!